Aurinia Pharmaceuticals Inc (AUPH)
R&D to Revenue
15.68%
Quarterly · Period ending:
AUPH R&D to Revenue
Latest reported15.68%period ending
Latest reported15.68%period ending
AUPH Quarterly R&D/Revenue (0.00% → 15.68%)
Latest values, visible window
High-resolution chart · PNG
AUPH r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 378.1981% | |
| 653.2928% | |
| 457.4929% | |
| 1,800.0015% | |
| 175% | |
| 264.6123% | |
| -100.0002% | |
| 125% | |
| 0% |